The measurement being addressed represents the expected values for a specific blood test used in the diagnosis of celiac disease. This laboratory assessment quantifies the amount of IgA antibodies targeting tissue transglutaminase (tTG) present in a patient’s serum. The reported spectrum of values helps clinicians determine if the antibody level is within normal limits, suggesting a low likelihood of the condition, or elevated, potentially indicating the presence of celiac disease and warranting further investigation.
Accurate interpretation of these values is crucial for timely and effective patient management. Early detection of celiac disease allows for dietary interventions to mitigate long-term complications, such as nutrient malabsorption and increased risk of certain cancers. The establishment and refinement of these values over time have improved diagnostic accuracy and reduced the need for invasive procedures like intestinal biopsies. Furthermore, these measurements provide a standardized benchmark for monitoring the efficacy of gluten-free diets in patients with confirmed celiac disease.
